AstraZeneca is acquiring Belgium-based EsoBiotec for $1 billion to expand its cell therapy capabilities, with the deal set to close in the second quarter.
AstraZeneca, the British-Swedish pharmaceutical and biotechnology joint venture, announced on Monday that it has reached an agreement to acquire EsoBiotec, according to a company press release.
The Belgium-based biotech firm has accepted AstraZeneca's $1 billion acquisition offer for its entire shareholding, with an initial payment of $425 million.
The deal is expected to be finalised in the second quarter of this year, subject to regulatory approvals and customary closing conditions.
"EsoBiotec will enhance and build upon the impact of our recent investments, representing a significant step towards realising our ambition to fully harness the potential of cell therapy," said Susan Galbraith, AstraZeneca's Executive Vice President.
Jean-Pierre Latere, CEO of EsoBiotec, stated: "We are excited to collaborate with AstraZeneca, a global leader in drug development, to advance our shared goal of delivering cost-effective, transformative cell therapies to a wider patient population. By combining our expertise and resources, we can accelerate the development of our in vivo platform, which utilises an innovative delivery technology with broad therapeutic potential."
EsoBiotec is a pioneering biotechnology company specialising in in vivo cell therapies for cancer, with early clinical studies showing promising results.
The company's Engineered NanoBody Lentiviral platform enhances the immune system's ability to combat cancer and has the potential to make cell therapy more accessible, reducing treatment times from weeks to just minutes.
Flights from Shiraz's main airport have been cancelled until 20:00 local time, according to Iranian media, as Iran and Israel continue exchanging stri...
Armenian Prime Minister Nikol Pashinyan's party is on course for victory, with Armenian media reporting that the country's Central Election Commission...
A powerful earthquake struck off the southern Philippine island of Mindanao on Monday (8 June), killing at least 32 people and triggering tsunami war...
The 79th Annual Tony Awards took place on Sunday (7 June) at Radio City Music Hall, celebrating the strongest performances of the Broadway season, wit...
Start your day informed with the AnewZ Morning Brief. Here are the top stories for the 8 June, covering the latest developments you need to know....
A groundbreaking study presented at ASCO reveals that AstraZeneca’s experimental pill camizestrant, when used based on blood test results, can halve the risk of breast cancer progression or death—potentially reshaping treatment for patients with hormone receptor-positive, HER2-negative breast cancer
AstraZeneca, opens new tab said it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including the arrest of its China president last year.
Counting is underway in Armenia's elections. The results of the vote are set to determine the political direction of the country of three million people for the next few years. Prime Minister Nikol Pashinyan is hoping to fend off challenges from several pro-Russia candidates to secure a third term.
Armenian Prime Minister Nikol Pashinyan's party is on course for victory, with Armenian media reporting that the country's Central Election Commission has completed the vote count in the parliamentary elections. An official announcement is still expected.
Armenian authorities arrested six candidates from the pro-Russian Strong Armenia bloc on Saturday, one day before voters were due to take part in parliamentary elections.
Azerbaijan's Foreign Ministry has confirmed the number of casualties its citizens suffered as a result of the 5 June drone attacks on the cargo ships Natra and Zircon in the Sea of Azov. In a statement, it said four Azerbaijani citizens were killed and four others were injured.
The results of Armenia’s parliamentary elections will determine the makeup of the National Assembly and shape the country's political direction for the foreseeable future. But in Armenia, the final result is not decided by vote percentages alone. Here's how it works.
A U.S. doctor who contracted Ebola while on a humanitarian mission in the Democratic Republic of Congo has recovered and been discharged from a hospital in Germany, according to officials.
Protesters in Nanyuki blocked roads and burned tyres after residents challenged a U.S. plan to house Americans exposed to Ebola at a nearby military base.
Global health organisation CEPI will provide around $60 million to Moderna and two other partners to speed up the development of vaccines targeting the Ebola Bundibugyo strain, which is currently driving an outbreak in eastern Democratic Republic of Congo.
The head of the World Health Organization (WHO) has warned that the Ebola outbreak in the Democratic Republic of Congo may be significantly larger than official figures suggest, following a visit to the country where he briefed President Felix Tshisekedi on the ongoing response.
Four nurses have recovered and been discharged after receiving treatment for Ebola in the Democratic Republic of Congo, the World Health Organisation (WHO) said.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment